220 related articles for article (PubMed ID: 32569477)
21. Interleukin-17 Pathophysiology and Therapeutic Intervention in Cystic Fibrosis Lung Infection and Inflammation.
Hsu D; Taylor P; Fletcher D; van Heeckeren R; Eastman J; van Heeckeren A; Davis P; Chmiel JF; Pearlman E; Bonfield TL
Infect Immun; 2016 Sep; 84(9):2410-21. PubMed ID: 27271746
[TBL] [Abstract][Full Text] [Related]
22. Evidence for the Involvement of Lipid Rafts and Plasma Membrane Sphingolipid Hydrolases in
Schiumarini D; Loberto N; Mancini G; Bassi R; Giussani P; Chiricozzi E; Samarani M; Munari S; Tamanini A; Cabrini G; Lippi G; Dechecchi MC; Sonnino S; Aureli M
Mediators Inflamm; 2017; 2017():1730245. PubMed ID: 29333001
[TBL] [Abstract][Full Text] [Related]
23. Fenretinide corrects newly found ceramide deficiency in cystic fibrosis.
Guilbault C; De Sanctis JB; Wojewodka G; Saeed Z; Lachance C; Skinner TA; Vilela RM; Kubow S; Lands LC; Hajduch M; Matouk E; Radzioch D
Am J Respir Cell Mol Biol; 2008 Jan; 38(1):47-56. PubMed ID: 17656682
[TBL] [Abstract][Full Text] [Related]
24. The reverse activity of human acid ceramidase.
Okino N; He X; Gatt S; Sandhoff K; Ito M; Schuchman EH
J Biol Chem; 2003 Aug; 278(32):29948-53. PubMed ID: 12764132
[TBL] [Abstract][Full Text] [Related]
25. Autophagy augmentation alleviates cigarette smoke-induced CFTR-dysfunction, ceramide-accumulation and COPD-emphysema pathogenesis.
Bodas M; Pehote G; Silverberg D; Gulbins E; Vij N
Free Radic Biol Med; 2019 Feb; 131():81-97. PubMed ID: 30500419
[TBL] [Abstract][Full Text] [Related]
26. Sphingolipids and acid ceramidase as therapeutic targets in cancer therapy.
Govindarajah N; Clifford R; Bowden D; Sutton PA; Parsons JL; Vimalachandran D
Crit Rev Oncol Hematol; 2019 Jun; 138():104-111. PubMed ID: 31092365
[TBL] [Abstract][Full Text] [Related]
27. Acid Ceramidase in Melanoma: EXPRESSION, LOCALIZATION, AND EFFECTS OF PHARMACOLOGICAL INHIBITION.
Realini N; Palese F; Pizzirani D; Pontis S; Basit A; Bach A; Ganesan A; Piomelli D
J Biol Chem; 2016 Jan; 291(5):2422-34. PubMed ID: 26553872
[TBL] [Abstract][Full Text] [Related]
28. Acid Ceramidase Protects Against Hepatic Ischemia/Reperfusion Injury by Modulating Sphingolipid Metabolism and Reducing Inflammation and Oxidative Stress.
Jiang Y; He X; Simonaro CM; Yi B; Schuchman EH
Front Cell Dev Biol; 2021; 9():633657. PubMed ID: 34026750
[TBL] [Abstract][Full Text] [Related]
29. Effect of antidepressant drugs on the brain sphingolipid system.
Jaddoa E; Masania J; Masiero E; Sgamma T; Arroo R; Sillence D; Zetterström T
J Psychopharmacol; 2020 Jul; 34(7):716-725. PubMed ID: 32403969
[TBL] [Abstract][Full Text] [Related]
30. Roles for C16-ceramide and sphingosine 1-phosphate in regulating hepatocyte apoptosis in response to tumor necrosis factor-alpha.
Osawa Y; Uchinami H; Bielawski J; Schwabe RF; Hannun YA; Brenner DA
J Biol Chem; 2005 Jul; 280(30):27879-87. PubMed ID: 15946935
[TBL] [Abstract][Full Text] [Related]
31. Ceramide in Pseudomonas aeruginosa infections and cystic fibrosis.
Becker KA; Grassmé H; Zhang Y; Gulbins E
Cell Physiol Biochem; 2010; 26(1):57-66. PubMed ID: 20502005
[TBL] [Abstract][Full Text] [Related]
32. Restoring Cystic Fibrosis Transmembrane Conductance Regulator Function Reduces Airway Bacteria and Inflammation in People with Cystic Fibrosis and Chronic Lung Infections.
Hisert KB; Heltshe SL; Pope C; Jorth P; Wu X; Edwards RM; Radey M; Accurso FJ; Wolter DJ; Cooke G; Adam RJ; Carter S; Grogan B; Launspach JL; Donnelly SC; Gallagher CG; Bruce JE; Stoltz DA; Welsh MJ; Hoffman LR; McKone EF; Singh PK
Am J Respir Crit Care Med; 2017 Jun; 195(12):1617-1628. PubMed ID: 28222269
[TBL] [Abstract][Full Text] [Related]
33. Frontline Science: Sphingosine rescues burn-injured mice from pulmonary Pseudomonas aeruginosa infection.
Rice TC; Seitz AP; Edwards MJ; Gulbins E; Caldwell CC
J Leukoc Biol; 2016 Dec; 100(6):1233-1237. PubMed ID: 27418352
[TBL] [Abstract][Full Text] [Related]
34. Potential role of acid ceramidase in conversion of cytostatic to cytotoxic end-point in pancreatic cancer cells.
Morad SA; Messner MC; Levin JC; Abdelmageed N; Park H; Merrill AH; Cabot MC
Cancer Chemother Pharmacol; 2013 Mar; 71(3):635-45. PubMed ID: 23263160
[TBL] [Abstract][Full Text] [Related]
35. The role of sphingolipids and ceramide in pulmonary inflammation in cystic fibrosis.
Becker KA; Riethmüller J; Zhang Y; Gulbins E
Open Respir Med J; 2010 Mar; 4():39-47. PubMed ID: 20556203
[TBL] [Abstract][Full Text] [Related]
36. Ceramide and sphingosine in pulmonary infections.
Seitz AP; Grassmé H; Edwards MJ; Pewzner-Jung Y; Gulbins E
Biol Chem; 2015 Jun; 396(6-7):611-20. PubMed ID: 25720061
[TBL] [Abstract][Full Text] [Related]
37. Cystic fibrosis airway epithelial Ca2+ i signaling: the mechanism for the larger agonist-mediated Ca2+ i signals in human cystic fibrosis airway epithelia.
Ribeiro CM; Paradiso AM; Carew MA; Shears SB; Boucher RC
J Biol Chem; 2005 Mar; 280(11):10202-9. PubMed ID: 15647273
[TBL] [Abstract][Full Text] [Related]
38. Chronic Pseudomonas aeruginosa lung infection in cystic fibrosis. A longitudinal study of immune complex activity and inflammatory response in sputum sol-phase of cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infections: influence of local steroid treatment.
Schiøtz PO; Jørgensen M; Flensborg EW; Faerø O; Husby S; Høiby N; Jacobsen SV; Nielsen H; Svehag SE
Acta Paediatr Scand; 1983 Mar; 72(2):283-7. PubMed ID: 6340415
[TBL] [Abstract][Full Text] [Related]
39. Disruption of sphingolipid metabolism augments ceramide-induced autophagy in preeclampsia.
Melland-Smith M; Ermini L; Chauvin S; Craig-Barnes H; Tagliaferro A; Todros T; Post M; Caniggia I
Autophagy; 2015 Apr; 11(4):653-69. PubMed ID: 25853898
[TBL] [Abstract][Full Text] [Related]
40. Glucosylceramide Critically Contributes to the Host Defense of Cystic Fibrosis Lungs.
Kovacic B; Sehl C; Wilker B; Kamler M; Gulbins E; Becker KA
Cell Physiol Biochem; 2017; 41(3):1208-1218. PubMed ID: 28427052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
